INTERNATIONAL PATENT: PETRA PHARMA CORPORATION FILES APPLICATION FOR "SOLID FORMS OF 6-CHLORO-3-[(1R)-1-[3,6-DIMETHYL-2-(2-METHYLINDAZOL-5-YL)-4-OXO-CHROMEN-8-YL]ETHOXY]PYRIDINE-2-CARBOXAMIDE"

GENEVA, Nov. 11 -- PETRA PHARMA CORPORATION (Lilly Corporate CenterIndianapolis, Indiana 46285) filed a patent application (PCT/US2025/026957) for "SOLID FORMS OF 6-CHLORO-3-[(1R)-1-[3,6-DIMETHYL-2-(2-METHYLINDAZOL-5-YL)-4-OXO-CHROMEN-8-YL]ETHOXY]PYRIDINE-2-CARBOXAMIDE" on Apr 30, 2025. With publication no. WO/2025/231053, the details related to the patent application was published on Nov 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): COATES, David Andrew (c/o Eli Lilly and CompanyPO Box 6288Indianapolis, Indiana 46206-6288), KUMINEK, Gislaine (c/o Eli Lilly and CompanyPO Box 6288Indian...